Poor Prognosis in Patients With Stage I and II Oral Tongue Squamous Cell CarcinomaRUSTHOVEN, Kyle; BALLONOFF, Ari; RABEN, David et al.Cancer. 2008, Vol 112, Num 2, pp 345-351, issn 0008-543X, 7 p.Article

Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancerBIANCO, Cataldo; GIOVANNETTI, Elisa; RICCIARDI, Simona et al.Clinical cancer research. 2006, Vol 12, Num 23, pp 7099-7107, issn 1078-0432, 9 p.Article

External beam radiotherapy in bone metastatic prostate cancer: Impact on patients' pain relief and quality of lifeDI LORENZO, Giuseppe; AUTORINO, Riccardo; BIANCO, A. Raffaele et al.Oncology reports. 2003, Vol 10, Num 2, pp 399-404, issn 1021-335X, 6 p.Article

Head and neck cancerARGIRIS, Athanassios; KARAMOUZIS, Michalis V; RABEN, David et al.Lancet (British edition). 2008, Vol 371, Num 9625, pp 1695-1709, issn 0140-6736, 15 p.Article

DOSIMETRIC EFFECT OF ONLINE IMAGE-GUIDED ANATOMICAL INTERVENTIONS FOR POSTPROSTATECTOMY CANCER PATIENTSDIOT, Quentin; OLSEN, Christine; KAVANAGH, Brian et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 2, pp 623-632, issn 0360-3016, 10 p.Article

Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima®) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenograftsGUSTAFSON, Daniel L; FREDERICK, Barbara; MERZ, Andrea L et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 2, pp 179-188, issn 0344-5704, 10 p.Article

Sparing the Larynx and Esophageal Inlet Expedites Feeding Tube Removal in Patients With Stage III-IV Oropharyngeal Squamous Cell Carcinoma Treated With Intensity-Modulated RadiotherapyAMIN, Neha; REDDY, Krishna; WESTERLY, David et al.The Laryngoscope. 2012, Vol 122, Num 12, pp 2736-2742, issn 0023-852X, 7 p.Article

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy : A secondary analysis of rtog trial 90-03RABINOVITCH, Rachel; GRANT, Barbara; BERKEY, Brian A et al.Head & neck. 2006, Vol 28, Num 4, pp 287-296, issn 1043-3074, 10 p.Article

Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levelsHELFRICH, Barbara A; RABEN, David; HIRSCH, Fred R et al.Clinical cancer research. 2006, Vol 12, Num 23, pp 7117-7125, issn 1078-0432, 9 p.Article

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancerRABEN, David; HELFRICH, Barbara A; CHAN, Dan et al.Seminars in oncology. 2002, Vol 29, Num 1, pp 37-46, issn 0093-7754, SUP4Article

Microcystic adnexal carcinoma of the face treated with radiation therapy: a case report and review of the literaturePUGH, Thomas J; LEE, Nancy Y; PACHECO, Theresa et al.Head & neck. 2012, Vol 34, Num 7, pp 1045-1050, issn 1043-3074, 6 p.Article

INITIAL RESULTS OF A PHASE I DOSE-ESCALATION TRIAL OF CONCURRENT AND MAINTENANCE ERLOTINIB AND REIRRADIATION FOR RECURRENT AND NEW PRIMARY HEAD-AND-NECK CANCERRUSTHOVEN, Kyle E; FEIGENBERG, Steven J; LANGO, Miriam et al.International journal of radiation oncology, biology, physics. 2010, Vol 78, Num 4, pp 1020-1025, issn 0360-3016, 6 p.Article

Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplificationROTHSCHILD, Brian L; SHIM, Ann H; RABEN, David et al.Cancer research (Baltimore). 2006, Vol 66, Num 16, pp 8017-8025, issn 0008-5472, 9 p.Article

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)BIANCO, Cataldo; TORTORA, Giampaolo; PEPE, Stefano et al.Clinical cancer research. 2002, Vol 8, Num 10, pp 3250-3258, issn 1078-0432, 9 p.Article

Management of primary cutaneous melanoma of the head and neck: The University of Colorado experience and a review of the literatureGIBBS, Peter; ROBINSON, William A; PEARLMAN, Nathan et al.Journal of surgical oncology. 2001, Vol 77, Num 3, pp 179-187, issn 0022-4790Article

Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose― and sequence―dependent mannerFLAIG, Thomas W; SU, Lih-En; MCCOACH, Caroline et al.BJU international (Papier). 2009, Vol 103, Num 12, pp 1729-1737, issn 1464-4096, 9 p.Article

Outcomes of Patients with N3 Neck Nodes Treated with ChemoradiationBALLONOFF, Ari; RABEN, David; RUSTHOVEN, Kyle E et al.The Laryngoscope. 2008, Vol 118, Num 6, pp 995-998, issn 0023-852X, 4 p.Article

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckBONNER, James A; HARARI, Paul M; OVE, Roger et al.The New England journal of medicine. 2006, Vol 354, Num 6, pp 567-578, issn 0028-4793, 12 p.Article

Report from the radiation oncology committee of the southwest oncology group (SWOG): Research Objectives Workshop 2003OKUNIEFF, Paul; MEYN, Raymond E; SMALLEY, Stephen R et al.American journal of clinical oncology. 2003, Vol 26, Num 5, pp 522-529, issn 0277-3732, 8 p.Article

Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not knowRABEN, David; HELFRICH, Barb; CIARDIELLO, Fortunato et al.Lung cancer. 2003, Vol 41, pp S15-S22, issn 0169-5002, SUP1Conference Paper

Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma CellsMARSHALL, Marianne E; HINZ, Trista K; KONO, Scott A et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5016-5025, issn 1078-0432, 10 p.Article

PHASE I TRIAL OF BORTEZOMIB AND CONCURRENT EXTERNAL BEAM RADIATION IN PATIENTS WITH ADVANCED SOLID MALIGNANCIESPUGH, Thomas J; CHANGHU CHEN; RABINOVITCH, Rachel et al.International journal of radiation oncology, biology, physics. 2010, Vol 78, Num 2, pp 521-526, issn 0360-3016, 6 p.Article

Survival and Patterns of Relapse in Patients With Oral Tongue CancerRUSTHOVEN, Kyle E; RABEN, David; SONG, John I et al.Journal of oral and maxillofacial surgery. 2010, Vol 68, Num 3, pp 584-589, issn 0278-2391, 6 p.Article

Effect of Radiation Techniques in Treatment of Oropharynx CancerRUSTHOVEN, Kyle E; RABEN, David; BALLONOFF, Ari et al.The Laryngoscope. 2008, Vol 118, Num 4, pp 635-639, issn 0023-852X, 5 p.Article

Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancerCHANGHU CHEN; KANE, Madeleine; SAID, Sherif et al.Journal of clinical oncology. 2007, Vol 25, Num 31, pp 4880-4886, issn 0732-183X, 7 p.Article